Molecular Diagnostics: Technologies and Global Markets

Report Code: BIO063E

Publish Date: May 2022

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global molecular diagnostics market should reach $42.6 billion by 2026 from $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 19.3% for the forecast period of 2021 to 2026.

Report Includes

  • 60 tables
  • An overview of the global market and technologies for molecular diagnostics
  • Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
  • Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
  • Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.

Report Scope

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $15.1 billion
Market size forecast $42.6 billion
Growth rate CAGR of 19.3% from 2021 to 2026
Units considered $ Millions
Segments covered Technology, Application, Region
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Key Market Drivers
  • High Incidences of Infectious Diseases
  • Increasing Incidences of Chronic Disease
  • Increasing Research and Development Budget
  • Increasing Healthcare Expenditures
Companies studied
ABBOTTAGILENT TECHNOLOGIES INC.
ALMAC GROUPBD
BIOMERIEUXBIO-RAD LABORATORIES INC.
CARDINAL HEALTHDANAHER CORP.
ELITECH GROUPGENERAL ELECTRIC
HOLOGIC INC.ILLUMINA INC.
MYRIAD GENETICS INC.GRIFOLS S.A.
PHILIPS HEALTHCAREQIAGEN
QUEST DIAGNOSTICS INC.F. HOFFMANN-LA ROCHE LTD.
SIEMENS HEALTHINEERS AGTHERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Molecular Diagnostics: Technologies and Global Markets204Free
Chapter- 1: Introduction7Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Overview5Free
Chapter- 4: Impact of the COVID-19 Pandemic3Free
Chapter- 5: Market Dynamics12Free
Chapter- 6: Market Breakdown by Technology15Free
Chapter- 7: Molecular Diagnostics by Application17Free
Chapter- 8: Market Breakdown by Region34Free
Chapter- 9: Regulations and Finance45Free
Chapter- 10: Patents19Free
Chapter- 11: Competitive Landscape2Free
Chapter- 12: Company Profiles43Free
Published - Oct-2017| Analyst - Jon Evans| Code - BIO063D

Report Highlights

The global molecular diagnostics market was valued at nearly $10.6 billion in 2016. The market is projected to grow at a compound annual growth rate (CAGR) of 14.3% from 2017 through 2022 to reach $12.2 billion by 2017 and $23.8 billion by 2022.

Report Includes 

  • An overview of the global market for molecular diagnostics
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of related issues, such as government regulations, reimbursement through insurance, patient confidentiality, and other legal ramifications
  • Identification of scientific challenges and advances, including the latest trends in the market
  • A relevant patent analysis
  • Comprehensive company profiles of major players in the field
Published - Jun-2015| Analyst - Jon Evans| Code - BIO063C

Report Highlights

The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.

Report Includes

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2012, 2013 and 2014 estimates for 2015, and projections of CAGRs through 2020.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends in the market.
  • A relevant patent analysis.
  • Comprehensive company profiles of major players in the field of molecular diagnostics.
Published - Mar-2013| Analyst - Jon Evans| Code - BIO063B

Report Highlights

In 2012, the global DNA diagnostics market was valued at $17.3 billion. The total market is projected to reach $20.1 billion in 2013 and nearly $36.5 billion by 2018, increasing at a compound annual growth rate (CAGR) of 12.6% from 2013 through 2018. 

Report Includes

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2010 through 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends.
  • Comprehensive company profiles and a patent analysis.
Published - Jun-2008| Analyst - Amy Brock| Code - BIO063A

Report Highlights

This Report:

  • By the end of 2008, the global DNA diagnostics market is expected to be valued at $10.6 billion. The total market is projected to grow at a compound annual growth rate (CAGR) of 13.7% to reach $20.1 billion in 2013.
  • PCR-based diagnostic assays should claim the largest share of the market in 2008 and be worth $5.4 billion. The segment will reach $9.5 billion in 2013, for a CAGR of 11.9%.
  • The fastest growing segment of the DNA diagnostics market is the LOAC market, which is expected to reach $890 million in 2008 and $2.1 billion in 2013, for a CAGR of 18.7%.

Related Reports

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - BIO126E

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Molecular Diagnostics: Technologies and Global Markets
Customize Report